Rare Disease Clinical Trials

The target audience for this initiative is physicians, nursing professionals and other members of the team caring for persons with rare diseases.

Provided by

Support for the activities in this curriculum has been made possible through educational grants from Sanofi Genzyme, Grifols, Novocure, and Ultragenyx Pharmaceutical.